4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010823
CHIEF MEDICAL OFFICER sold 20,000 shares at $25.07 ($501,478)
- CHIEF MEDICAL OFFICER acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Collins Helen Louise · CHIEF MEDICAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $2.48 | $49,600 | 20,000 | D |
| 2024-04-11 | Sale : show line 2 in the form 10b5-1 | −20,000 | $25.07 | $501,478 | 0 | D |
| Open-market sales · 20,000 sh · avg $25.07 · $501,478 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −20,000 | 267,084 | D |
Loading xslF345X05/form4-04152024_110437.xml…